Vacinas COVID-19 e outros imunobiológicos intervalos preconizados / COVID-19 vaccines and other immunobiological drugs recommended intervals
Arq. Asma, Alerg. Imunol
; 5(2): 113-114, abr.jun.2021. ilus
Article
ي Pt
| LILACS
| ID: biblio-1398821
المكتبة المسؤولة:
BR2717.9
RESUMO
Com o início do programa de vacinação contra a COVID-19 no Brasil, surgiu uma série de questionamentos relacionados ao uso dos imunizantes. Neste documento, o grupo de estudo da COVID-19 da Associação Brasileira de Alergia e Imunologia (ASBAI) avalia as evidências científicas e se posiciona em relação aos intervalos preconizados entre a administração das vacinas contra o SARS-CoV-2 e dos imunobiológicos.
ABSTRACT
With the beginning of the COVID-19 vaccination program in Brazil, a series of questions related to the use of vaccines arose. In this document, the COVID-19 study group of the Brazilian Association of Allergy and Immunology (ASBAI) assesses the scientific evidence and takes a stand for the recommended intervals between the administration of SARS-CoV-2 vaccines and that of immunobiological drugs.
Key words
النص الكامل:
1
الفهرس:
LILACS
الموضوع الرئيسي:
COVID-19 Vaccines
/
COVID-19
/
ChAdOx1 nCoV-19
نوع الدراسة:
Guideline
المحددات:
Humans
اللغة:
Pt
مجلة:
Arq. Asma, Alerg. Imunol
موضوع المجلة:
Biologia
/
Cincia
السنة:
2021
نوع:
Article